|
|
|
|
| LEADER |
01815nam a22003495i 4500 |
| 001 |
000281071 |
| 005 |
20210722100013.0 |
| 007 |
cr nn 008mamaa |
| 008 |
150310s2015 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781493924325
|
| 024 |
7 |
|
|a 10.1007/978-1-4939-2432-5
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Gene Therapy for HIV and Chronic Infections /
|c edited by Ben Berkhout, Hildegund C.J. Ertl, Marc S. Weinberg.
|
| 250 |
|
|
|a 1st ed. 2015.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2015.
|
| 300 |
|
|
|a XVI, 236 p. 41 illus., 35 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a American Society of Gene & Cell Therapy,
|v 848
|
| 505 |
0 |
|
|a Gene Therapies for Hepatitis C Virus -- Recent Advances in Use of Gene Therapy to Treat Hepatitis B Virus Infection -- U1interference (U1i) for antiviral approaches -- Gene therapy strategies to block HIV-1 replication by RNA interference -- HIV and Ribozymes -- Editing CCR5: a novel approach to HIV gene therapy -- Synthetic DNA approach to Cytomegalovirus vaccine/immune therapy -- Vector-mediated antibody gene transfer for infectious diseases -- HIV latency and the non-coding RNA therapeutic landscape -- C peptides as entry inhibitors for gene therapy -- Aptamer-siRNA chimeras for HIV .
|
| 650 |
|
0 |
|a Gene therapy.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
1 |
4 |
|a Gene Therapy.
|
| 650 |
2 |
4 |
|a Immunology.
|
| 650 |
2 |
4 |
|a Biomedicine, general.
|
| 700 |
1 |
|
|a Berkhout, Ben.
|e editor.
|
| 700 |
1 |
|
|a Ertl, Hildegund C.J.
|e editor.
|
| 700 |
1 |
|
|a Weinberg, Marc S.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|